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Background: Copy number variations at 2p11.2 have been rare and to our knowledge, no abnormal phenotype
with an interstitial 2p11.2 duplication has yet been reported. Here we report the first case with syndromic
intellectual disability associated with microduplication at 2p11.2.
Results: We revisited a white female subject with a chromosome translocation, t(8;10)(p23;q23)mat and a 10q
telomeric deletion suspected by G-banding 30 years ago. This female with severe intellectual disability, no speech,
facial dysmorphism, intractable epilepsy, recurrent infection, and skeletal abnormalities has been observed
from the birth until her death. The karyotype analysis reconfirmed the previously reported chromosome
translocation with a revision as 46,XX,t(8;10)(p23.3;q23.2)mat by adding more detail in chromosomal sub-bands. The
array comparative genomic hybridization, however, did not detect the 10q terminal deletion originally reported, but
instead, revealed a 390 kb duplication at 2p11.2; 46,XX,t(8;10)(p23.3;q23.2)mat.arr[hg 19] 2p11.2(85469151x2,85474356-
85864257x3,85868355x2). This duplication region was confirmed by real-time quantitative PCR and real-time reverse
transcriptase quantitative PCR.
Conclusions: We suggest three positional candidate genes for intellectual disability and recurrent infection based
upon gene function and data from real-time reverse transcriptase quantitative PCR—VAMP8 and RNF181 for intellectual
disability and CAPG for recurrent infection.
Keywords: Array CGH, CAPG, Copy number variation, Duplication, Intellectual disability, Recurrent infection, RNF181,
2p11.2, VAMP8Background
A variety of terminal 2p duplications known as partial
2p trisomy are the unbalanced chromosomal rearrange-
ments resulting from malsegregation of various balanced
translocations [1-3]. Interpretation of the clinical pheno-
types of carriers with these unbalanced translocations is
complicated due to the co-existence of terminal mono-
somy and terminal trisomy. Different isolated duplica-
tions within the 2p region had been reported in more
than 20 patients, but they vary in size and location, ran-
ging from 2p12 to 2p25 [4-7]. These duplications are* Correspondence: hkim@gru.edu
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unless otherwise stated.associated with a syndromic phenotype including intel-
lectual disability, growth and psychomotor retardation,
delayed bone age, congenital heart abnormalities, pul-
monary hypoplasia, hypoplastic kidney, genital anomaly,
anencephaly, neural tube defects, finger and toe ab-
normalities, or dysmorphic facial features encompassing
hypertelorism, prominent forehead, broad nasal bridge,
low-set ear, and micrognathia [4-7]. Because the size and
location of these 2p duplications may vary from individ-
ual to individual, comparison of overlapping regions for
defining a minimal candidate region associated with a
particular phenotype will be a useful strategy for identi-
fying the causative gene as exemplified in the mapping
of deletions [8,9].
Due to the limited resolution of banding and staining pat-
terns of chromosomes in the pre-FISH (FISH-fluorescent
in situ hybridization) and pre-CGH (CGH-comparative. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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misinterpretations of cytogenetic aberrations in the re-
ported cases, which complicated attempts to assign a
unique phenotype to a specific chromosome band. Here
we revisited a case reported 30 years ago [10] and failed to
confirm an ostensible 10q deletion. Instead, we identified
a cryptic 2p11.2 microduplication by a microarray in the
affected female subject. Some of her clinical features were
developed years later in her life. To our knowledge, this is
the first case with syndromic intellectual disability asso-
ciated with an interstitial 2p11.2 duplication. Genotype/
phenotype relationships have been discussed.
Results
Clinical report in a 30 year time period
The patient is a 30 year old white female with severe in-
tellectual disability, a severe static encephalopathy, med-
ically intractable epilepsy, and facial dysmorphism. She
was first evaluated at the age of 10 months because of
gastroenteritis and middle ear infection [10]. At that
time, her height, weight and head circumference were in
the 3rd percentile for chronological age. She is the first
living child of healthy non-consanguineous marriage.
The father was 42 years old and the mother with a previ-
ous spontaneous abortion was 26 years old at the birth
of their daughter. Prenatal screening demonstrated nor-
mal alpha-fetoprotein levels for gestational age and a nor-
mal ultrasound, but studies indicated an Rh-sensitized
status. The subject was a 2,700 g female at 35 weeks of
gestation born by cesarean section.
After at the age of one year, she was able to sit and
look into the eyes of anyone who spoke to her with
responding smiles. However, the direction of her gaze
was difficult to determine because of her convergent
strabismus. She did not show any autistic behavior as ev-
idenced by her continual demands on her mother. At
the age of two years, she started to babble words such as
mama, water, etc. Her facial appearances from 3 years to
30 years of age are shown chronologically in Figures 1A-D.
When she was evaluated at 10 months of age, her pheno-
type was as follows: hypotonia, long and narrow palpebral
fissures, long eyelashes, prominent eyebrow, mild hyperte-
lorism, broad nasal bridge, long philtrum, short neck, the
trunk and extremities of normal proportion with hirsut-
ism, redundant subcutaneous tissue on arms, legs, and the
dorsum of hands and feet, bilateral simian crease, infantile
external genitalia, and convergent strabismus [10]. She
began walking at 5 years of age.
At 9 years, she was diagnosed with epilepsy, reporting
myoclonic seizures with atypical absences. The electro-
encephalography (EEG) showed generalized 2 Hz spike-
and-slow waves. At this time she lost her ability to
verbalize simple words. She was started on valproic acid
and then vigavatrin was added. Her EEG then showedanterior right temporal epileptiform discharges. Because
of valproic acid side effects including hypothyroidism,
teeth, and gum damage, this medication was replaced by
clonazepam. Despite treatment, she continued to have
seizures. She frequently had complex partial seizures
with a moderate response to lamotrigine and oxcarbaze-
pine. Olanzapine was also administered because of psy-
chomotor excitation with episodes of autoaggression.
Brain MRI without contrast revealed cortical dysplasia
and asymmetric lateral ventricles with an enlarged right
ventricle at the age of 14 years (Figure 2). Corrective
surgery for her strabismus was performed at 12 years of
age. In addition, orthopedic surgery for her severe flaccid
flatfeet was also successfully performed by lengthening
of the calcaneus with a homologous graft from her iliac
crest at 16 years of age (Figures 1E-H).
In her latest evaluation, the 30-year-old subject still
suffers from intractable epilepsy. She has had growth,
but she is below the third percentile. She has a severe
mental and psychomotor delay with independent gait,
but still no language. Additionally, she has global mus-
cular atrophy, hypotonia, joint hyperflexibility (except
for her elbows and knees which were rigid), scoliosis,
and facial dysmorphism characterized by a long thin face
with prognathia and high nasal bridge (Figure 1D). The
mouth is usually open with sialorrhea, a full lower lip and
a thin upper lip, showing thickened gums (Figure 1C),
possibly related to antiepileptic medications. Several teeth
are missing due to the first exodontia surgery at age 22
and the subsequent exodontia surgery of her remaining
teeth, which showed decay at the age of 30. Her maxillo-
facial malformation worsened during adolescence with re-
peated changes of antiepileptic medications, which also
caused inflammatory gum processes, hypersalivation,
tooth loss, dental caries, and retraction of bone.
The proband also has a low hairline, backward rota-
tion of the ears, and small hands with hypoplastic finger-
nails and dry palmar and plantar surfaces. In addition,
she has a fungal infection on the skin of her hands exclu-
sively that has provoked a severe dermatitis (Figures 1I
and J). This infection has been recurrent throughout her
life. A recent brain MRI performed at the age of 29 did
not confirm the previous diagnosis of cortical dysplasia,
suggesting natural healing of the affected brain area. She
died at the age of 31 years and 8 months under a grand-
mal type of convulsion which took place during her bath
and could not be controlled.
The detection of microduplication at 2p11.2
Prenatal cytogenetic analysis using amniotic fluid showed
a female fetus with an inherited chromosome transloca-
tion, t(8;10)(p23;q23) shared with her mother. The father’s
karyotype was normal. When she was evaluated for devel-
opmental delay, her karyotype was reported as monosomy
Figure 1 Facial phenotype of the patient. The frontal view of patient was shown chronologically at the age of 3 years showing strabismus (A),
at the age of 12 years after the surgery to correct strabismus. She had normal teething before taking anticonvulsant (B), at the age of 18 years
showing the side effects of damaged teeth and thickened gum from antiepileptic drugs (C), and at the age of 30 years after the exodontias
surgery of the rest of decayed teeth with facial dysmorphism characterized by long and thin face with prognathia and high nasal bridge (D). She
also had severe flaccid flatfeet (E, F), which were successfully corrected by an orthopedic surgery lengthening the calcaneus with a homologuous
graft from the iliac crest at the age of 16 years (G, H). At the age of 31 years, she had fungal infection on the skin of her both hands that
provoked a severe dermatitis (I, J).
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FISH using probes in this region did not confirm this
deletion (data not shown). Another high resolution karyo-
type performed on peripheral blood lymphocytes using
standard methods and G-banding techniques con-
firmed that the patient has a chromosome translocation,
46,XX,t(8;10)(p23.3;q23.2)mat, shared with her asymp-
tomatic mother and younger sister. Methylation studies of
the 15q11-q13 region demonstrated the presence of twofragments with sizes of 6.6 kb and 3.4 kb, indicating
normal methylation status. Therefore a deletion or
uniparental disomy in the critical imprinted region of
Prader-Will and Angelman syndromes was highly un-
likely (data not shown) However, array CGH analysis
revealed a heterozygous 390 kb interstitial duplication
(Chr2: 85,474,356-85,864,257 [hg 19]) in band 2p11.2
with a maximum size of 399 kb (Chr2: 85,469,151-
85,868,355 [hg 19]) (Figure 3A).
Figure 2 The brain MRI views without contrast at the age of 14 years. They showed cortical dysplasia and asymmetric lateral ventricles with
an enlarged right ventricle.
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found in the patient, the nomenclature is revised as 46,
XX,t(8;10)(p23.3;q23.2)mat.arr[hg 19] 2p11.2(85469151x2,
85474356-85864257x3,85868355x2).
The confirmation of duplicated region by real-time
quantitative PCR
The duplicated region was detected in the patient only
and confirmed by real-time quantitative PCR (qPCR)
(Figure 3C). The mRNA expression levels of TCF7L1
and USP39 were not different among patient (II-1), her
mother (I-2), or her sister (II-2) by qRT-PCR using two
primer pairs from each gene (Table 1, data not shown).
The mRNA expression levels of CAPG, VAMP8, and
RNF181 were doubled in the duplication patient com-
pared to her two normal sister and mother by qRT-PCR
using two primer pairs designed within CAPG and one
primer pair from VAMP8 and RNF181, respectively
(Figures 3D-F, Table 1). No amplicon of the putative
fusion gene USP39/TCF7L1 was obtained from RT-PCR,
suggesting it is not expressed (Figure 4, Table 1).
Discussion
It may seem surprising that the reinvestigation of this
chromosome translocation, 46,XX,t(8;10)(p23.2;q23.2)
mat has spanned a 30 year time period. Since this chro-
mosome translocation was inherited from the healthy mo-
ther to the affected and unaffected daughters (Figure 3B), a
pathological role of this translocation in the phenotype of
the affected daughter was excluded. A previously reported
10q23-qter deletion was ruled out by FISH and array
CGH, the latter of which instead identified a cryptic 390 kb
duplication at 2p11.2 encompassing 15 genes (Figure 3A,
Table 2). This genomic duplication was confirmed by
qPCR (Figure 3C), suggesting its pathogenic role as a cryp-
tic chromosome rearrangement not readily detected byconventional karyotype analysis done in 1983 [10]. The de
novo status of this duplication is likely, but could not be
confirmed because her father is unwilling to participate.
Among the genes duplicated, the following CNVs have
been identified in healthy control persons, thereby po-
tentially ruling out them as candidate genes if gene dos-
age effect is underlying mechanism: a 7.8 kb deletion
involving all 4 exons within the gene TGOLN2 [11], a
28 kb duplication containing two genes, MAT2A and
GGCX [12], a 36 kb deletion encompassing whole gene
RNF181 [13], and a 12 kb deletion encompassing exons
4–6 [14] and a 5.6 kb deletion encompassing exons 7–9
[15] of the gene USP39 (Table 2).
Interstitial deletions encompassing 2p11.2 are particu-
larly rare, with only seven cases reported to date [16,17].
Among them, the interstitial deletion of 2p11.2-2p12
was confirmed in only three cases by array CGH [16],
high-resolution CGH [17], or qPCR [17]. These deletions
ranged in size from 7.5 to 11.4 Mb, encompassing the
390 kb duplicated region of our case. The patient with
an 11.4 Mb deletion had psychomotor retardation, mild
cutaneous syndactylies, pectus carinatum, hyperlordosis,
clubfeet, single umbilical artery, and facial abnormalities,
such as low-set ears, broad nasal bridge, frontal bossing,
and dolichocephaly [16]. In family 3, a son with a 7.5 Mb
deletion presented with impairment of physical develop-
ment, and intellectual disability, language delay including
a pronunciation problem, suspected epilepsy, recurrent
Wilms tumor, a large head with frontal bossing, a flat face,
and low-set abnormally molded ears [17]. His mother with
the same deletion had features similar to her son, such as
abnormally molded ears, a severe pronunciation problem,
and intellectual disability [17].
Two obstacles hampered us to compare the overlapping
phenotype and genomic regions between our duplication
patient and three patients with deletions encompassing
Figure 3 Three candidate genes showing overexpression in qRT-PCR among 15 genes within the 2p11.2 duplication identified by array
CGH and confirmed by qPCR. (A) Array CGH showing the internal boundaries of minimal 390 kb heterozygous interstitial duplication at 2p11.2
showing 15 annotated genes involved. Three positional candidate genes, CAPG with recurrent infection and VAMP8 as well as RNF181 with
intellectual disability, were depicted in red. Vertical arrows show duplicated region in array CGH and transcription direction is indicated by an
arrow for each gene. (B) Pedigree of the family. Patient (II-1) with a multisystem developmental disorder and 2p11.2 microduplication shared the
chromosome translocation with her asymptomatic mother (I-2) and younger sister (II-2). (C) The qPCR with genomic DNAs of the patient (II-1),
her healthy sisier (II-2), and healthy mother (I-1) showed the duplication at 2p11.2 in the patient only from the primer pairs #2 and #3 of the
duplicated region. (D, E, F) qRT-PCR showing the overexpression of three genes. The mRNA expression of each gene was increased by 1.7-2.1
folds in the patient compared to the unaffected mother and the sister.
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genes is involved in both deletions and our duplication,
and whether increased or decreased gene dosage would
give rise to the same phenotype. Secondly, the genomic
regions of 7 reported deletion cases are so large that they
could contain more than one gene for a specific pheno-
type such as intellectual disability. In this circumstance,
the simple comparison of overlapping regions in two
groups of inappropriately different sized CNVs is not
meaningful because our duplication is only 390 kb and
the smallest deletion among 7 deletion cases is 7.5 Mb
containing a large number of genes.
Therefore, we analyzed known and deduced functions
of genes within the duplicated region. While the chromo-
some band 2p11.2 of 7.2 Mb contains many genes, fifteenannotated genes are located in 390 kb duplicated re-
gion of our case; TCF7L1, TGOLN2, RETSAT, ELMOD3,
CAPG, SH2D6, LOC100630918, MAT2A, GGCX, VAMP8,
VAMP5, RNF181, TMEM150A, C2orf68, and USP39
(Figure 3A, Table 2). These are all protein-coding genes,
except the non-coding RNA LOC100630918.
The multisystemic disorder in our patient suggests
that it is caused by more than one gene or by a single
gene encoding a transcription factor regulating various
target genes. Among the genes in the duplicated region,
TCF7L1 (transcription factor 7-like 1, formerly named
TCF3, MIM 604652) is a mediator of the WNT signaling
pathway [18]. This gene encodes a transcription factor,
which is a member of the T-cell factor/lymphoid enhan-
cer factor. Importantly, TCF7L1 physically interacts with
Figure 4 Prediction of a putative fusion gene USP39/TCF7L1 due to the duplication. If the distal and proximal duplication breakpoints
truncate two genes, TCF7L1 and USP39, it will produce a putative fusion gene USP39/TCF7L1, because the transcription direction of both genes is
same. In order to amplify the putative fusion gene, a forward primer Fusion-USP39-F and a reverse primer Fusion-TCF7L1-R were used (Table 1).
Table 1 Primers used for qPCR, qRT-PCR, and RT-PCR
Primer name Gene name (GenBank accession number) exon number Primer sequence (5′→ 3′) *Tm (°C)
qPCR
primer pair #1F TCF7L1 exon1 F: ACGAGCTGATCCCCTTCC 60.16
primer pair #1R (NM_031283) R: CTGCTCTGGTTCTCCGACTC 60.14
primer pair #2F TCF7L1 exon12 F: GCAAGAAGCCATGTGTTCAG 59.45
primer pair #2R (NM_031283) R: GGTTTCTGGTTTGGTGGTGA 60.79
primer pair #3F TMEM150A exon8 F: TACGAGTTTGGGGCAGTCTC 60.25
primer pair #3R (NM_001031738) R: CCTCCCCAGACCTTAGATCA 59.79
GAPDH-F GAPDH exon6 F: GATCATCAGCAATGCCTCCT 60.4
GAPDH-R (NM_001289745) R: ATGGCATGGACTGTGGTCAT 60.4
qRT-RCR
primer pair #1F TCF7L1 exon1 F: ACGAGCTGATCCCCTTCC 60.16
primer pair #1R (NM_031283) R: CTGCTCTGGTTCTCCGACTC 60.14
primer pair #2F TCF7L1 exon12 F: GCAAGAAGCCATGTGTTCAG 59.45
primer pair #2R (NM_031283) R: GGTTTCTGGTTTGGTGGTGA 60.79
primer pair #4F USP39 exon5 F: ATGTTCCTCCTCTCCGGAAC 60.46
primer pair #4R (NM_006590) R: AGCATCTCATGGGGAGACAC 60.08
primer pair #5F USP39 exon10 F: GACCTCATTGCCAACATCGT 60.23
primer pair #5R (NM_006590) exon11 R: GTGTGATCATCTGGGGAAGG 60.33
CAPG-1F CAPG exon3 F: CTCCATTCCCAGGCTCAGT 60.21
CAPG-1R (NM_001747) R: GAAACCTCTTCTGGGCCATT 60.44
CAPG-2F CAPG exon9 F: CGAAAAGCGAATGAGAAGGA 60.46
CAPG-2R (NM_001747) exon10 R: CCACCCTCATTTCCAGTCC 60.31
VAMP8-F VAMP8 exon 3 F: GAGGAAGCCAGTGAAGGTGG 60.6
VAMP8-R (NM_003761) R: CAGATCCTCTGTCTTGTTGCG 59.44
RNF181-F RNF181 exon1 F: ACCAACATGCTGCTGGAGC 60
RNF181-R (NM_016494) R: TCTCAACCACAGTCTTGGCAG 59
GAPDH-F GAPDH exon6 F: GATCATCAGCAATGCCTCCT 60.4
GAPDH-R (NM_001289745) R: ATGGCATGGACTGTGGTCAT 60.4
RT-PCR
Fusion-USP39-F USP39 exon6 F: ATGTTCCTCCTCTCCGGAAC 60.46
Fusion-TCF7L1-R TCF7L1 (USP39/TCF7L1) exon5 R: TGTCTTTGGATCGATCTCTGG 60.20
*Tm: melting temperature.
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Table 2 Genes located at the duplicated region of 2p11.2














None Homozygous mutant mice
exhibit severe embryological
defects particularly affecting the
cardiovascular system, nervous
system, and digestive system.
Not affected by our duplication








None No knock-out mice. A 7.8 kb
deletion involving all 4 exons
within the gene was reported in
a normal control person.




























None Inactivation of this loci results in
impaired immune cell motility
which manifests in homozygous
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non-coding RNA
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like disorder with multiple
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(OMIM 610842)
Only 50% of expected Ggcx(−/−)
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latter animals die uniformly at
birth of massive intra-abdominal
hemorrhage. A 28 kb duplication
containing this gene and TAT2A
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None No knock-out mice.
A 12 kb deletion encompassing
exons 4–6 and a 5.6 kb deletion
encompassing exons 7–9 was
reported in normal control
persons.
Not affected by our duplication
based on qRT-PCR result.
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MIM 116806] [19], mutations of which cause severe in-
tellectual disability with absent or very limited speech,
microcephaly, and spasticity [20]. Since proteins accom-
plish most of their functions by interacting with other
molecules, we wondered whether TCF7L1 might be in-
volved in intellectual disability by increasing gene dosage
from the duplication. Theoretically, TCF7L1 at the distal
duplication junction would express one intact and one
truncated transcript, respectively (Figure 4). The trun-
cated one with 3′ end is most likely not expressed due
to the lack of the promotor and putative start codon.
This was confirmed by qRT-PCR with two different pri-
mer pairs—#1 and #2 designed from the 5′ end and 3′
end of this gene (Figures 3A and 4, Table 1), which failed
to demonstrate any change in expression in the patient,
her healthy mother, and sister (data not shown). This
finding makes it highly unlikely that TCF7L1 is a candi-
date for intellectual disability.
The gene USP39 (ubiquitin specific peptidase 39, MIM
611594) is also a good candidate for intellectual disabil-
ity since alterations of the ubiquitin/proteasome system
(UPS) may engender neuronal dysfunction leading to
neurological disease and intellectual disability [21]. This
gene truncated at the proximal duplication junction
would consequently be predicted to produce one intact
and one truncated transcript with the 5′ end (Figure 4).
Two primer pairs #4 and #5 were designed from the 5′
end and 3′ end of this gene, respectively, for qRT-PCR
(Figure 4 and Table 1). The amount of transcript (from
two different regions) was not different in the patient,
her unaffected mother, and sister (data not shown), sug-
gesting that this gene is not affected by the duplication.
Since the transcription of two truncated genes,
TCF7L1 and USP39, is in the same direction, there is a
possibility of producing a fusion gene (Figure 4). Prac-
tically, it is unlikely that the fusion gene is expressed.
If it had been expressed, the amplicon from primer
pair #2 would have shown overexpression due to add-
itional expression from the second half of the fusion
gene comprising of partial TCF7L1 with the 3′ end
(Figure 4). This hypothesis that the fusion gene was
not expressed is confirmed because RT-PCR failed to
demonstrate the presence of the putative fusion geneUSP39/TCF7L1 (data not shown), using a forward primer
from USP39 and a reverse primer from TCF7L1, (Figure 4
and Table 1).
After eliminating TCF7L1 and USP39, two partially
duplicated but unaffected genes, VAMP8 and RNF181
become plausible candidate genes for intellectual disabil-
ity seen in our patient among the 13 genes duplicated at
2p11.2. VAMP8 (vesicle-associated membrane protein 8,
MIM 603177) encodes a protein involved in the fusion
of synaptic vesicles with the presynaptic membrane. It
interacts with YWHAE (tyrosine 3-monooxygenase/tryp-
tophan 5-monooxygenase activation protein, epsilon
polypeptide, MIM 605066) [22]. Heterozygous knock-
out mice show neuron migration defects, mild defects in
spatial working memory, and possibly enhanced anxiety
in an elevated plus-maze test. This phenotype coupled
with the genetic association between one SNP in the 5′
flanking region of YWHAE and schizophrenia suggested
this gene a possible susceptibility gene for this psychi-
atric disorder [23]. This makes VAMP8 an attractive
candidate gene for intellectual disability. RNF181 (ring
finger protein 181, MIM 612490) has E3 ubiquitin ligase
activity [24] and because ubiquitination plays a crucial
role in neurodevelopment as aforementioned [21], this is
a good candidate for intellectual disability.
At least, five genes, HUWE1 (MIM 300697), PARK2
(MIM 602544), UBE3A (MIM 601623), UBE3B (MIM
608047), RNF216 (MIM 609948), encoding E3 ubiquitin
ligases, have been involved in intellectual disability or
another neurological phenotype. Mutations of HUWE1
(HECT, UBA and WWE domain containing 1) are as-
sociated with X-linked intellectual disability [25] and
PARK2 (Parkinson protein 2) is mutated in Parkinson
patients [26]. Genetic alterations of UBE3A (ubiquitin
protein ligase E3A) cause Angelman syndrome charac-
terized by intellectual disability, seizures, frequent smiling
and laughter, and abnormal gait [27]. Biallelic loss-of-
function mutations of UBE3B (ubiquitin protein ligase
E3B) cause autosomal recessive blepharophimosis-ptosis-
intellectual-disability syndrome [28]. Inactivating muta-
tions of RNF216 (ring finger protein 216) cause Gordon
Holmes syndrome, which is characterized by cerebel-
lar ataxia, dementia, and hypogonadotropic hypogona-
dism [29].
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ated with syndromic X-linked intellectual disability is a
scaffold subunit of E3 ubiquitin-protein ligase complex
[30] and UBE2A (ubiquitin-conjugating enzyme E2A,
MIM 312180) encoding E2 ubiquitin-conjugating en-
zyme are associated with X-linked intellectual disability
[31]. An unaffected individual with a 36 kb deletion
encompassing whole gene RNF181 has been reported as
aforementioned [13]. However, we still cannot exclude
the possibility that overexpression from a duplication,
which was confirmed by qRT-PCR (Figure 3F), rather than
haploinsufficiency, might cause intellectual disability.
Among the duplicated genes, CAPG [capping protein
(actin filament), gelsolin-like, MIM 153615] encodes a
macrophage-capping protein, which controls actin-based
motility in non-muscle cells. Homozygous mutant mice
lacking this gene manifest increased susceptibility to
some bacterial infections [32]. This gene might also have
had some influence on the patients’ phenotype as a re-
sult of the duplication, given that qRT-PCR showed its
overexpression in our patient with recurrent fungal in-
fection on the skin of her hands (Figures 1I, J, and 3D).
The patient commonly placed her hands into her mouth,
biting her fingers with self-injurious behavior. Her skin
lesions were sometimes complicated with fungal infec-
tions and treated with antifungal cream, clotrimazole.
Lastly, two genes, ELMOD3 and GGCX, involved in
recessive disorders were ruled out as candidate genes be-
cause of the absence of associated clinical features of
these two genes in our patient with a likely autosomal
dominant phenotype due to the heterozygous dupli-
cation. A homozygous missense mutation of ELMOD3
(ELMO/CED-12 domain containing 3, MIM 615427)
was found by whole exome sequencing combined with
homozygosity mapping in a Pakistani family with auto-
somal recessive nonsyndromic deafness-88 (DFNB88,
MIM 615429) [33], while homozygous missense and
compound heterozygous mutations of GGCX (gamma-
glutamyl carboxylase, MIM 137167) cause vitamin K-
dependent coagulation defect (MIM 277450) [34,35] and
pseudoxanthoma elasticum-like Disorder with multiple
coagulation factor deficiency (MIM 610842) [36].Conclusions
In summary, here we report the first interstitial duplica-
tion of 2p11.2 associated with syndromic intellectual dis-
ability. Based on the functional characterization and
qRT-PCR of the genes, we suggest three positional
candidate genes—VAMP8 and RNF181 for intellectual
disability and CAPG for recurrent infection. In con-
cert with the qRT-PCR data, we propose increased
gene dosage as the underlying mechanism of the two
phenotypes.Methods
For high resolution karyotype, peripheral blood lympho-
cytes from the patient, mother, and younger sister were
cultured with Phytohematoagglutinin and harvested for
cytogenetic analysis using standard techniques. Chromo-
some analysis was performed on GTL-banded chromo-
somes at an approximately 550 band level.
Methylation studies of the 15q11-q13 region was per-
formed with enzymes HindIII and CfoI and Southern
blot analysis with probe PW71B.
DNA copy number variants were investigated using a
400 k whole genome oligonucleotide array (GPL9777)
employing the protocols for array CGH provided by the
manufacturer (Agilent, Santa Clara, USA). Image ana-
lysis, normalization, and annotation were done with Fea-
ture Extraction 10.5.1.1 (Agilent, Santa Clara, USA)
using the default settings. Data visualization and fur-
ther analysis was performed with GenomeCAT (http://
www.molgen.mpg.de/~abt_rop/molecular_cytogenetics/
CGHPRO.html). CNVs were determined by circular bin-
ary segmentation [37].
To confirm the duplicated region, three primer pairs
were designed for real-time quantitative PCR (qPCR)—
pairs #1 and #2 from the 5′ and 3′ ends of the gene
TCF7L1, respectively, and #3 from the gene TMEM150A
(Figure 3A, Table 1). Primer pair #1 was designed from
the outside of the duplicated region as a negative con-
trol, whereas primer pairs #2 and #3 were designed from
within the duplicated region (Figure 3A). qPCR was
performed using an ABI 7300 Realtime PCR system
(Applied Biosystem, Foster City, CA, USA) according
to the manufacturer’s instructions (Figure 3C). The
copy number was measured relative to GAPDH.
For real-time reverse transcriptase quantitative PCR
(qRT-PCR), RNA was extracted from lymphoblastoid
cell lines by Trizol Reagent (Invitrogen, Calsbad, CA,
USA). Total RNA was reverse-transcribed into cDNA by
RevertAid First-strand cDNA synthesis (Thermo Fisher
Scientific, Glen Burnie, MA, USA). qRT-PCR for TCF7L1,
CAPG,VAMP8, RNF181, and USP39 was performed with
SYBR (RT2 SYBR Green, Qiagen, Gaithersburg, MD,
USA) on an ABI 7300 Realtime PCR system (Applied
Biosystem, Foster City, CA, USA) according to the manu-
facturer’s instructions. For three genes, TCF7L1, CAPG,
and USP39, two primer pairs were designed per gene,
whereas one primer pair was designed for two genes,
VAMP8 and RNF181 (Table 1).
To amplify the putative fusion gene USP39/TCF7L1,
reverse transcriptase PCR (RT-PCR) was performed with
a forward primer from USP39 and a reverse primer from
TCF7L1, respectively. The forward primer was designed
from exon 6 of USP39 because the breakpoint was lo-
cated between intron 7 (minimum breakpoint) and in-
tron 10 (maximum breakpoint), and an exon 7 fragment
Jun et al. Molecular Cytogenetics 2014, 7:52 Page 10 of 11
http://www.molecularcytogenetics.org/content/7/1/52is too small to analyze. The reverse primer was designed
complementary to exon 5 of TCF7L1, since the break-
point lies in intron 3 and exon 4 is too short (Figure 4,
Table 1).
To better define the clinical phenotype associated with
copy number variation of 2p11.2, we compared this case
with previously reported interstitial deletions encom-
passing 2p11.2 and assigned individual phenotypes to in-
dividual genes in the duplicated region.
Ethical approval was granted for this study by an in-
terdisciplinary institutional reviewer board of Georgia
Regents University.
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